What is NDC 69097-904?

69097-904 is the product NDC for Oseltamivir Phosphate, Oseltamivir phosphate 6 mg/mL for suspension, listed with the FDA by Cipla USA, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Cipla USA, Inc, NDC labeler code 69097. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oseltamivir Phosphate?

107 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oseltamivir Phosphate NDC 69097-904

NDC codes

FDA NDC Directory

Product NDC (as listed)69097-904Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69097-0904Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69097-904-43	6909709044369097090443	1 BOTTLE in 1 CARTON (69097-904-43) / 60 mL in 1 BOTTLEMarketed from Jan 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oseltamivir Phosphate
Generic name (nonproprietary): oseltamivir phosphate
Active ingredients: Oseltamivir phosphate — 6 mg/mL
Dosage form: For suspension
Route: Oral
Labeler: Cipla USA, IncNDC labeler code 69097
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212858
Marketing start: Jan 16, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Neuraminidase Inhibitors (Mechanism)
Identifiers: Product ID 69097-904_4e8c50c0-4026-4047-ac0b-6d8bbb56f923SPL ID 4e8c50c0-4026-4047-ac0b-6d8bbb56f923SPL set ID 7d04f367-8f62-4f63-bac9-717d14f555a5RxCUI 1115698UNII 4A3O49NGEZUPC 0369097904432
Pharmacologic class: Neuraminidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469097090443 followed by a unit qualifier and the quantity

Package 69097-0904-43. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 2, 2023.

Indications (excerpt from the label)

Oseltamivir Phosphate for Oral Suspension is an influenza neuraminidase inhibitor (NAI) indicated for: Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. ( 1.1 ) Prophylaxis of influenza A and B in patients 1 year and older. ( 1.2 ) Limitations of Use : Not a substitute for annual influenza vaccination. ( 1.3 ) Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. ( 1.3 ) Not recommended for patients with end-stage renal disease not undergoing dialysis. ( 1.3 ) 1.1 Treatment of Influenza Oseltamivir Phosphate for Oral Suspension is …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69097-904

What is NDC 69097-904?: 69097-904 is the product NDC for Oseltamivir Phosphate, Oseltamivir phosphate 6 mg/mL for suspension, listed with the FDA by Cipla USA, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oseltamivir Phosphate.
What is the active ingredient?: Oseltamivir phosphate.
Who is the labeler?: Cipla USA, Inc, NDC labeler code 69097. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oseltamivir Phosphate?: 107 other product NDCs are listed under this name. See all Oseltamivir Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oseltamivir Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4770	70518-4770-00
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Limited	46708-769	46708-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Inc.	62332-769	62332-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	SuspensionOral	HEC Pharm USA Inc.	72303-0851	72303-0851-01
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4066	68788-4066-01
oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-101	72673-0101-10
oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-102	72673-0102-10
Oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-321	42677-0321-01
Oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-320	42677-0320-01
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-322	42677-0322-01

All 108 Oseltamivir Phosphate NDCs

Other NDCs under ANDA 212858

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212858
Product	Strength	Form · route	Labeler	Product NDC
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Exelan Pharmaceuticals, Inc.	76282-739